We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

HAEMONETICS

Haemonetics Corporation’s comprehensive portfolio of devices, information management, and consulting services offers ... read more Featured Products: More products

Download Mobile App




Vascular Closure System Permits Same-Day Discharge

By HospiMedica International staff writers
Posted on 14 Oct 2021
Print article
Image: The Vascade MVP system places a collagen patch in ablation access sites (Photo courtesy of Haemonetics)
Image: The Vascade MVP system places a collagen patch in ablation access sites (Photo courtesy of Haemonetics)
An innovative venous vascular closure device allows same-day discharge following atrial fibrillation (AF) cardiac ablation.

The Haemonetics (Braintree, MA, USA) Vascade MVP is an integrated vascular closure system that combines a small, collapsible bi-convex low profile nitinol mesh disc and thrombogenic collagen hemostatic patches to accelerate coagulation at the access site after cardiac electrophysiology procedures. The mesh disc is first approximated to the inner wall of the vessel wall to temporarily quench bleeding; a collagen patch is then released into the tissue tract, expanding approximately 13 times, and the mesh disc is then removed.

The expanded collagen ensures the residual tissue tract is sufficiently filled following completion of the ablation procedure, and is rapidly resorbed, enabling future access procedures. The Vascade MVP system has been shown to reduce time to ambulation, reduce total post-procedure time, time to hemostasis, and time to discharge eligibility in patients undergoing catheter-based procedures utilizing 6-12F inner diameter procedural sheaths, with single- or multiple-access sites in one or both limbs.

“COVID has accelerated the need to enhance safety and efficacy to optimize the patient experience in meaningful ways,” said Chris Simon, President and CEO of Haemonetics. “Vascade MVP earning the first and only indication for same-day discharge for AF ablation patients speaks to our industry leadership and continued commitment to improving the standards of care.”

Vascular access complications are frequent, and a host of strategies have therefore been developed to decrease bleeding and access site complications. Closure devices have emerged as an alternative to traditional mechanical compression, as they can reduce total time to hemostasis, reduce patient discomfort associated with prolonged bed rest, improve early mobilization and patient satisfaction, and decrease health expenditure.

Related Links:
Haemonetics

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Forceps
BiClamp LAP

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.